Literature DB >> 24402487

Cerebrovascular neurosurgery in evolution: the endovascular paradigm.

Grant C Sorkin1, Travis M Dumont, Jorge L Eller, Maxim Mokin, Kenneth V Snyder, Elad I Levy, Adnan H Siddiqui, L Nelson Hopkins.   

Abstract

Endovascular technique represents an important, minimally invasive approach to treating cerebrovascular disease. In this article, we discuss the origins of endovascular neurosurgery as a discipline in the context of important technical milestones, evidence-based medicine, and future cerebrovascular neurosurgical training. Cerebrovascular neurosurgery has seen a steady, convergent evolution toward the surgeon capable of seamless incorporation of open and endovascular approaches to any complex vascular disease affecting the central nervous system. Neurosurgery must assume the leadership role in the multidisciplinary neurovascular team.

Entities:  

Mesh:

Year:  2014        PMID: 24402487     DOI: 10.1227/NEU.0000000000000222

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  3 in total

1.  Surgical Reconstruction to Allow Endovascular Access for Flow Diversion of Giant Cavernous Aneurysm: A Combined Approach.

Authors:  Visish M Srinivasan; Ascher Kaufmann; Peter Kan; Edward A Duckworth
Journal:  Cureus       Date:  2018-03-28

2.  Feasibility of a customizable training environment for neurointerventional skills assessment.

Authors:  Marie Teresa Nawka; Uta Hanning; Helena Guerreiro; Fabian Flottmann; Noel Van Horn; Jan-Hendrik Buhk; Jens Fiehler; Andreas Maximilian Frölich
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

3.  Microsurgical and endovascular treatment of un-ruptured cerebral aneurysms by European hybrid neurosurgeons to balance surgical skills and medical staff management.

Authors:  Abdul Rahman Al-Schameri; Som Thakur; Michael Kral; Christoph Schwartz; Slaven Pikija; Camillo Sherif; Friedrich Weymayr; Bernd Richling
Journal:  Acta Neurochir (Wien)       Date:  2021-02-10       Impact factor: 2.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.